Doxorubicin eluting beads - 2: Methods for evaluating drug elution and in-vitro:in-vivo correlation

Journal of Materials Science: Materials in Medicine

Volumn 19, Issue 2, 2008, Pages 767-775

  Gonzalez, M Victoria ^a,b   Tang, Yiqing ^a   Phillips, Gary J ^b   Lloyd, Andrew W ^b   Hall, Brenda ^a   Stratford, Peter W ^a   Lewis, Andrew L ^a  

^a BIOCOMPATIBLES UK LTD   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; DIFFUSION; ION EXCHANGE; TUMORS;

DOXORUBICIN ELUTING BEADS; FICKIAN DIFFUSION MODEL; MICROSPHERICAL EMBOLISATION AGENT;

DRUG PRODUCTS;

DOXORUBICIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; AUTOMATION; CALCULATION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DIFFUSION; DIFFUSION COEFFICIENT; DISSOLUTION; DRUG DOSE ESCALATION; DRUG FORMULATION; DRUG RELEASE; ELUTION; HUMAN; ION EXCHANGE; KINETICS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REPRODUCIBILITY; SLOW DRUG RELEASE;

ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; CHEMOEMBOLIZATION, THERAPEUTIC; DELAYED-ACTION PREPARATIONS; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; MICROSPHERES; NEOPLASMS; POLYVINYL ALCOHOL;

EID: 39049123800     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-006-0040-y     Document Type: Article

References (28)

1. A. L. LEWIS, M. V. GONZALEZ, B. HALL, et al., JVIR 17(2) (2006) 335
2. A. L. LEWIS, M. V. GONZALEZ, S. W. LEPPARD, et al., J. Mater. Sci. Mater. Med. doi: 10.1007/s10856-007-3068-8
3. B. SPERKER, T. E. MURDTER, M. SCHICK, et al., J. Pharmacol. Exp. Ther. 281(2) (1997) 914
4. W. J. JUSKO, J. Pharm. Sci. 60 (1971) 892
5. M. J. BOYER and I. F. TANNOCK, in "Cellular and Molecular Basis of Chemotherapy. The Basic Science of Oncology" (Toronto, MacGraw-Hill Health Professions Division, 1998) p. 350
6. US Pharmacopeia 28, (2005)
7. R. Y. CHEUNG, R. KUBA, A. M. RAUTH and X. Y. WU, J. Control Release 94 (2004) 25
8. F. AMYOT, V. BOUDY, K. JURSKI and J. COUNORD, ITBM-RBM 23 (2002) 285
9. C. CHRETIEN, V. BOUDY, P. ALLAIN and J. C. CHAUMEIL, J Control Release 96 (2004) 369
10. M. VARELA, M. I. REAL, M. BURREL, et al., J. Hepatol. 47 (2007) 159
11. J. M. LLOVET, M. I. REAL, X. MONTAÑA, et al., Lancet 359 (2002) 1734
12. P. JOHNSON, C. KALAYCI and N. DOBBS, J. Hepatol. 13(1) (1991) 120
13. J. RICHARDS, in "The Role of Polymer Permeability in the Control of Drug Release. Polymer Permeability" (London, Elsevier Applied Science Publisher, 1985) Chapt. 6, p. 217
14. T. HIGUCHI, J. Pharm. Sci. 52(12) (1963) 1145
15. Z. LIU, R. CHEUNG, X. Y. WU, J. R. BALLINGER, et al., J. Control Release 77 (2001) 213
16. A. SAWAYA, R. FICKAT, J. P. BENOIT, et al., J. Microencapsul. 5 (1988) 23
17. C. L. SCHAUF, M. MOFFETT and S. B. MOFFETT, in "Human Physiology. Foundations and Frontiers" (Edward. F. Murphy, 1990)
18. X. Y. WU, G. ESHUN and Y. ZHOU, J. Pharm. Sci. 87 (1998) 255
19. D. REICHENBERG, J. Am. Chem. Soc. 75 (1953) 589
20. M. ABDEKHODAIE and X. Y. WU, Biomaterials 27 (2006) 3652
21. G. BOYD, A. ADAMSON and L. MYERS J. Am. Chem. Soc. 69 (1947) 2836
22. F. AMYOT, K. JURSKI, G. DUFAUX and G. GUIFFANT, Int. Comm. Heat Mass Transfer 20(9) (2002) 623
23. X. LI, D.J. HIRSH, D. CABRAL-LILLY, A. ZIRKEL, et al., Biochim. Biophys. Acta 1415 (1998) 23
24. GUIDANCE FOR INDUSTRY: extended release oral dosage forms: development, evaluation and application of in vitro/in vivo correlations, Food and Drug Administration, (1997)
25. G. SCHELIECKER, C. SCHMIDT, S. FUSCHS, et al., J. Control Release 94 (2004) 25
26. N. CHIDAMBARAM and D. J. BURGESS, AAPS Pharm. Sci. 1(3) (1999) article 11
27. G. MINOTTI, P. MENNA and E. SALVATORELLI, Pharmacol. Rev. 56(2) (2004) 185
28. K. HONG, A. KHWAJA, E. LIAPI, et al., Clin. Cancer Res. 12(8) (2006) 2563